Clinical Trials Browser

Phase NA × Completed × Lymphoma, B-Cell × Clear all

Lymphoma, Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05556239 2025-12-08

STAY-STRONG

Phase NA Completed

42 enrolled

Lymphoid

Hodgkin Disease, Motor Activity, Lymphoma, B-Cell, Sarcopenia

NCT05260203 2024-11-06

MargheRITA

Phase NA Completed

124 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT05510596 2024-08-09

MR-ICANS

Phase NA Completed

25 enrolled

Lymphoid

Cytokine Release Syndrome, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

45 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04213469 2024-01-05

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

Phase NA Completed

20 enrolled

Lymphoid

Lymphoma, B-Cell

Clinical Trials

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

STAY-STRONG

MargheRITA

MR-ICANS

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

PD1-CD19-CART in Patients With r/r B-cell Lymphoma